By Leah Schnurr
NEW YORK (Reuters) - U.S. stocks sagged on Tuesday as investors paused after a seven-session string of gains and the Bundesbank's chief warned the euro zone's crisis has not ended.
On Wall Street, investors' confidence has grown in recent months, leading to a gain of more than 10 percent for the year by the Dow and nearly 9 percent by the S&P 500. Signs of improvement in the economy and the Federal Reserve's quantitative easing have helped to drive the advance.
Heading into Tuesday, both the Dow and benchmark S&P 500 index had rallied for seven consecutive sessions, with the Dow closing at another record high on Monday. The S&P is within reach of its all-time closing high of 1,565.15, set on October 9, 2007.
"It's natural to have pauses," said John Fox, co-manager of the FAM Value Fund in Cobleskill, New York.
Adding to the weakness, Jens Weidmann, head of Germany's central bank and a member of the European Central Bank's governing council, said the euro zone crisis was not over.
Pullbacks during the rally so far this year have not been too deep as investors look for a good place to buy. Market moves have also been more muted in recent days, even as stocks have ground higher.
"The individual days are not huge ... but certainly if you string a few of them together, it's a nice increase in stock prices," said Fox.
Tech shares, which have lagged the rally, pulled indexes lower as heavyweights such as Apple and Google tumbled. Apple dropped 1.7 percent to $430.57 and Google fell 1.2 percent to $824.87, while the S&P tech sector lost 0.8 percent.
Offsetting the decline, the healthcare sector rose 0.3 percent. Traditionally considered a defensive bet, the sector has been one of the leaders of the rally so far this year, accelerating by nearly 12 percent.
In the short-term, however, healthcare appears to be overbought, suggesting investors may start to put their money elsewhere. Based on the relative strength index, healthcare has been overbought since the beginning of the month.
The Dow Jones industrial average slipped 14.16 points, or 0.10 percent, to 14,433.13. The Standard & Poor's 500 Index fell 5.53 points, or 0.36 percent, to 1,550.69. The Nasdaq Composite Index lost 18.66 points, or 0.57 percent, to 3,234.22.
Merck shares gained 2.8 percent to $44.89 to help curb declines on both the Dow and S&P after the pharmaceutical company said an outside board had allowed it to continue a trial assessing its Vytorin cholesterol treatment.
Yum Brands Inc rose 2.1 percent to $69.25 after the parent company of the KFC restaurant chain reported an unexpected rise in February sales in China.
(Editing by Kenneth Barry)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
